‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
(www.theguardian.com)
I wouldn’t get your hopes up
The trick is in asking who owns the patent. I suspect you're going to see a bunch of Chinese/Indian generics that cost pennies on the US dollar, because they see an economic benefit in people not having HIV that Americans can't grasp.